Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

12.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

8.9K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.9K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

6.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

1.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-restricted eating, liver health, and fecal microbiota in adults with overweight or obesity: a randomized controlled trial.

JHEP reports : innovation in hepatology·2026
Same author

Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma.

Frontiers in cell and developmental biology·2026
Same author

A guide for establishing patient-derived organoids from bile samples obtained during endoscopic procedures and performing gene expression knockdown.

Frontiers in cell and developmental biology·2026
Same author

Epigenetic drug control of Clec4g/LSECtin expression reduces fibrosis burden in cirrhosis.

Hepatology communications·2026
Same author

Pharmacological strategies to enhance the response of hepatoblastoma to chemotherapy through MDR1 inhibition.

Acta pharmacologica Sinica·2026
Same author

Overall survival, clinical significance and biochemical composition of 'white bile' in patients with impaired biliary drainage: a systematic review.

Journal of physiology and biochemistry·2026

Related Experiment Video

Updated: May 3, 2026

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

5.1K

Amphiregulin.

Carmen Berasain1, Matías A Avila1

  • 1Division of Hepatology and Gene Therapy, CIMA, University of Navarra, Avda. Pio XII, n55, 31008 Pamplona, Spain; CIBERehd, Clinica Universidad de Navarra, Avda. Pio XII, n55, 31008 Pamplona, Spain.

Seminars in Cell & Developmental Biology
|January 28, 2014
PubMed
Summary

Amphiregulin (AREG), an epidermal growth factor receptor (EGFR) ligand, is involved in cell signaling and development. Dysregulation of AREG is linked to inflammatory and neoplastic diseases, highlighting its translational potential.

Keywords:
AmphiregulinCancerCell signalingChemoresistanceEpidermal growth factor receptor (EGFR)ProliferationSurvival

More Related Videos

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians
04:37

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians

Published on: May 12, 2019

17.0K
Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
10:05

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

13.5K

Related Experiment Videos

Last Updated: May 3, 2026

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
08:20

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Published on: May 21, 2019

5.1K
Reproductive Techniques for Ovarian Monitoring and Control in Amphibians
04:37

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians

Published on: May 12, 2019

17.0K
Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
10:05

Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins

Published on: August 7, 2014

13.5K

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Amphiregulin (AREG) is a ligand for the epidermal growth factor receptor (EGFR), a key transmembrane tyrosine kinase.
  • AREG functions both as a membrane-anchored protein for juxtacrine signaling and as a secreted factor (autocrine/paracrine) after proteolytic cleavage by TACE/ADAM17.
  • AREG expression and release are induced by diverse stimuli, including inflammatory mediators, hormones, and xenobiotics.

Purpose of the Study:

  • To review the fundamental aspects of AREG structure, function, and regulation.
  • To elucidate AREG's distinct role among EGFR family ligands.
  • To identify emerging research areas in AREG with potential clinical applications.

Main Methods:

  • Literature review of existing research on Amphiregulin.
  • Analysis of AREG's molecular interactions and signaling pathways.
  • Comparative analysis of AREG within the broader context of EGFR ligands.

Main Results:

  • AREG binding to EGFR activates intracellular signaling cascades controlling cell survival, proliferation, and motility.
  • Physiological roles of AREG include mammary gland, bone, and oocyte development.
  • Chronic elevation of AREG is associated with inflammatory and neoplastic conditions.

Conclusions:

  • AREG is a critical regulator of cellular processes with significant physiological roles.
  • Aberrant AREG signaling contributes to various pathologies, particularly inflammation and cancer.
  • Further research into AREG mechanisms and regulation holds promise for therapeutic development.